| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1109857
[patent_doc_number] => 06805870
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-19
[patent_title] => 'Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament'
[patent_app_type] => B1
[patent_app_number] => 08/693052
[patent_app_country] => US
[patent_app_date] => 1996-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8682
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/805/06805870.pdf
[firstpage_image] =>[orig_patent_app_number] => 08693052
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/693052 | Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament | Aug 19, 1996 | Issued |
| 08/686342 | HCV PEPTIDE COMPOSITIONS | Jul 24, 1996 | Abandoned |
Array
(
[id] => 6834621
[patent_doc_number] => 20030162167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'METHOD OF DETECTING ANTIBODIES TO HCV'
[patent_app_type] => new
[patent_app_number] => 08/686983
[patent_app_country] => US
[patent_app_date] => 1996-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 145
[patent_figures_cnt] => 145
[patent_no_of_words] => 73510
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162167.pdf
[firstpage_image] =>[orig_patent_app_number] => 08686983
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/686983 | METHOD OF DETECTING ANTIBODIES TO HCV | Jul 24, 1996 | Abandoned |
Array
(
[id] => 3736334
[patent_doc_number] => 05785969
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-28
[patent_title] => 'Method and pharmaceutical and diagnosis compositions for drug targeting'
[patent_app_type] => 1
[patent_app_number] => 8/600988
[patent_app_country] => US
[patent_app_date] => 1996-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2137
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/785/05785969.pdf
[firstpage_image] =>[orig_patent_app_number] => 600988
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/600988 | Method and pharmaceutical and diagnosis compositions for drug targeting | Jul 21, 1996 | Issued |
| 08/679640 | RECOMBINANT ALPHAVIRUS-BASED VECTORS WITH REDUCED INHIBITION OF CELLULAR MACROMOLECULAR SYNTHESIS | Jul 11, 1996 | Abandoned |
Array
(
[id] => 3924979
[patent_doc_number] => 05876992
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'Method and formulation for stabilization of enzymes'
[patent_app_type] => 1
[patent_app_number] => 8/675697
[patent_app_country] => US
[patent_app_date] => 1996-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8452
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/876/05876992.pdf
[firstpage_image] =>[orig_patent_app_number] => 675697
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/675697 | Method and formulation for stabilization of enzymes | Jul 2, 1996 | Issued |
Array
(
[id] => 3790109
[patent_doc_number] => 05780243
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-14
[patent_title] => 'Methods for the quantitative analysis of organic compounds'
[patent_app_type] => 1
[patent_app_number] => 8/671754
[patent_app_country] => US
[patent_app_date] => 1996-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7214
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/780/05780243.pdf
[firstpage_image] =>[orig_patent_app_number] => 671754
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/671754 | Methods for the quantitative analysis of organic compounds | Jun 27, 1996 | Issued |
Array
(
[id] => 4135311
[patent_doc_number] => 06060103
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-09
[patent_title] => 'Method for extending the shelf life of a carbonated beverage within a plastic bottle by maintaining a low fill temperature'
[patent_app_type] => 1
[patent_app_number] => 8/669103
[patent_app_country] => US
[patent_app_date] => 1996-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2318
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/060/06060103.pdf
[firstpage_image] =>[orig_patent_app_number] => 669103
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/669103 | Method for extending the shelf life of a carbonated beverage within a plastic bottle by maintaining a low fill temperature | Jun 23, 1996 | Issued |
Array
(
[id] => 3875596
[patent_doc_number] => 05804371
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-08
[patent_title] => 'Hapten-labelled peptides'
[patent_app_type] => 1
[patent_app_number] => 8/615279
[patent_app_country] => US
[patent_app_date] => 1996-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8795
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/804/05804371.pdf
[firstpage_image] =>[orig_patent_app_number] => 615279
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/615279 | Hapten-labelled peptides | Jun 12, 1996 | Issued |
Array
(
[id] => 4244491
[patent_doc_number] => 06207160
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-27
[patent_title] => 'aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies'
[patent_app_type] => 1
[patent_app_number] => 8/660092
[patent_app_country] => US
[patent_app_date] => 1996-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 25915
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/207/06207160.pdf
[firstpage_image] =>[orig_patent_app_number] => 660092
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/660092 | aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies | Jun 5, 1996 | Issued |
Array
(
[id] => 3873486
[patent_doc_number] => 05728386
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-17
[patent_title] => 'Thermostable varicella zoster virus'
[patent_app_type] => 1
[patent_app_number] => 8/652483
[patent_app_country] => US
[patent_app_date] => 1996-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5991
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/728/05728386.pdf
[firstpage_image] =>[orig_patent_app_number] => 652483
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/652483 | Thermostable varicella zoster virus | May 21, 1996 | Issued |
Array
(
[id] => 1313445
[patent_doc_number] => 06607727
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-19
[patent_title] => 'Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus'
[patent_app_type] => B1
[patent_app_number] => 08/591502
[patent_app_country] => US
[patent_app_date] => 1996-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 25
[patent_no_of_words] => 45524
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/607/06607727.pdf
[firstpage_image] =>[orig_patent_app_number] => 08591502
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/591502 | Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus | May 19, 1996 | Issued |
Array
(
[id] => 4080424
[patent_doc_number] => 06024962
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Vaccine against mumps containing a Jeryl-Lynn virus strain'
[patent_app_type] => 1
[patent_app_number] => 8/649654
[patent_app_country] => US
[patent_app_date] => 1996-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5967
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/024/06024962.pdf
[firstpage_image] =>[orig_patent_app_number] => 649654
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/649654 | Vaccine against mumps containing a Jeryl-Lynn virus strain | May 12, 1996 | Issued |
Array
(
[id] => 4234434
[patent_doc_number] => 06080392
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'Composition in the form of an aerosol mousse based on polyurethane and anionic polymer'
[patent_app_type] => 1
[patent_app_number] => 8/645117
[patent_app_country] => US
[patent_app_date] => 1996-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5108
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 363
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080392.pdf
[firstpage_image] =>[orig_patent_app_number] => 645117
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/645117 | Composition in the form of an aerosol mousse based on polyurethane and anionic polymer | May 12, 1996 | Issued |
| 08/635514 | STABILIZED ANTIHEPATITIS-B VACCINE TABLETS | Apr 21, 1996 | Abandoned |
| 08/602835 | ASSAY METHOD | Apr 17, 1996 | Abandoned |
Array
(
[id] => 4411937
[patent_doc_number] => 06265567
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Isolated FrpB nucleic acid molecule'
[patent_app_type] => 1
[patent_app_number] => 8/628434
[patent_app_country] => US
[patent_app_date] => 1996-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15025
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265567.pdf
[firstpage_image] =>[orig_patent_app_number] => 628434
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/628434 | Isolated FrpB nucleic acid molecule | Apr 4, 1996 | Issued |
Array
(
[id] => 3831126
[patent_doc_number] => 05814468
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Methods of enumerating receptor molecules for specific binding partners on formed bodies and in solution'
[patent_app_type] => 1
[patent_app_number] => 8/624014
[patent_app_country] => US
[patent_app_date] => 1996-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27003
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814468.pdf
[firstpage_image] =>[orig_patent_app_number] => 624014
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/624014 | Methods of enumerating receptor molecules for specific binding partners on formed bodies and in solution | Mar 26, 1996 | Issued |
Array
(
[id] => 4063395
[patent_doc_number] => 05895653
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-20
[patent_title] => 'Adjuvant based on colloidal iron compounds'
[patent_app_type] => 1
[patent_app_number] => 8/622013
[patent_app_country] => US
[patent_app_date] => 1996-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5080
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/895/05895653.pdf
[firstpage_image] =>[orig_patent_app_number] => 622013
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/622013 | Adjuvant based on colloidal iron compounds | Mar 25, 1996 | Issued |
Array
(
[id] => 3734452
[patent_doc_number] => 05753234
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Single-shot vaccine formulation'
[patent_app_type] => 1
[patent_app_number] => 8/613830
[patent_app_country] => US
[patent_app_date] => 1996-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6728
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753234.pdf
[firstpage_image] =>[orig_patent_app_number] => 613830
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/613830 | Single-shot vaccine formulation | Mar 10, 1996 | Issued |